☆ 4.6 Article

Pandemic-response adenoviral vector and RNA vaccine manufacturing

NPJ VACCINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biotechnology & Applied Microbiology

Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs

Carina C. D. Joe et al.

Summary: In response to the COVID-19 pandemic, we have developed an effective vaccine based on novel manufacturing technologies, allowing for large-scale production and distributed manufacturing to ensure international supply security and cost-effectiveness.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Vaccines and routine immunization strategies during the COVID-19 pandemic

Ener Cagri Dinleyici et al.

Summary: The COVID-19 pandemic has posed serious challenges globally, leading to a rapid decline in childhood immunization coverage rates in many countries. As the pandemic continues, there may be serious consequences related to insufficient childhood vaccination rates.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Editorial Material Biotechnology & Applied Microbiology

COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies

Shyam Rele

Summary: The cautiously optimistic view on COVID-19 vaccine development is contingent upon addressing key technical barriers and supply chain issues to ensure successful production and distribution.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Review Respiratory System

Unprecedented: the toxic synergism of Covid-19 and climate change

Manish Joshi et al.

Summary: The review examines the constellations of causes and consequences of the Covid-19 pandemic and climate change, highlighting their commonalities despite appearing unrelated. Both pandemics are caused by human behaviors and underscore the global nature of the issues at hand. These unprecedented events have similar societal impacts and disproportionately affect marginalized populations.

CURRENT OPINION IN PULMONARY MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Looking beyond COVID-19 vaccine phase 3 trials

Jerome H. Kim et al.

Summary: Following the announcement of COVID-19 vaccine efficacy in clinical trials, a comprehensive strategy is needed for global vaccination, including manufacturing, support, supply coordination, equitable distribution, and logistics. Additionally, addressing scientific questions to improve vaccine efficacy is crucial for ending the pandemic effectively and efficiently.

NATURE MEDICINE (2021)

添加到收藏夹

Article Immunology

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Zoltan Kis et al.

Summary: This article evaluates the techno-economic feasibility of producing RNA vaccines for global mass vaccination campaigns, highlighting performance differences in production processes for different RNA vaccines and the varying resources, production scales, and speeds required in different dosage scenarios.

VACCINES (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

Rajeka Lazarus et al.

Summary: This study assessed the safety of concomitant administration of COVID-19 and influenza vaccines. The results showed that simultaneous vaccination with ChAdOx1 or BNT162b2 and an age-appropriate influenza vaccine raised no safety concerns and did not adversely affect immune responses.

LANCET (2021)

添加到收藏夹

Review Medicine, General & Internal

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Olivier J. Wouters et al.

Summary: The COVID-19 pandemic may not end globally until vaccines that protect against severe disease and drive herd immunity are widely distributed. While vaccines have been authorized for human use in many countries, achieving global control of COVID-19 requires not only licensed vaccines but also mass production, affordable pricing, global allocation, and wide local deployment.

LANCET (2021)

添加到收藏夹

Article Immunology

Promoting versatile vaccine development for emerging pandemics

Joshua T. Monrad et al.

Summary: The importance of rapid and versatile development of emergency medical countermeasures such as vaccines has been highlighted by the ongoing COVID-19 pandemic. The role of platform vaccines and prototype pathogen research in modern vaccine development was discussed, with suggestions on improving funding approaches to promote vaccine R&D for emerging pandemics. The article emphasizes the need for funders to invest in versatile platform technologies to accelerate pandemic vaccine development and to recognize the full social value of increasing overall preparedness for emerging infectious diseases.

NPJ VACCINES (2021)

添加到收藏夹

News Item Medicine, General & Internal

Vaccinating against covid and flu at same time is safe, study shows

Jacqui Wise

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Immunology

Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK

Dauda Ibrahim et al.

Summary: This study implements a new framework that supports the planning and delivery of vaccination campaigns, by segmenting and prioritizing target populations, estimating vaccination timeframe and workforce requirements, predicting logistics costs, and facilitating the distribution of vaccines, to reveal the necessary resources required and their associated costs ahead of vaccination campaign, for efficient planning and cost-effective delivery of COVID-19 vaccination.

VACCINES (2021)

添加到收藏夹

News Item Multidisciplinary Sciences

WHAT IT WILL TAKE TO VACCINATE THE WORLD AGAINST COVID-19

Aisling Irwin

Summary: The report outlines a range of challenges, from harnessing the power of mRNA vaccines to the battle for temporary relief on intellectual property rights.

NATURE (2021)

添加到收藏夹

Article Immunology

Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases

Damien van de Berg et al.

Summary: Rapid-response vaccine production platform technologies, including RNA vaccines, are being developed to combat viral epidemics and pandemics. The research team applies the Quality by Design framework to enhance rapid-response RNA vaccine manufacturing against known and future viral pathogens, utilizing a qualitative methodology and a quantitative bioprocess model.

NPJ VACCINES (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device

Sarah J. Shepherd et al.

Summary: The study presents a scalable, parallelized microfluidic device (PMD) that can simultaneously operate 128 mixing channels, achieving over 100 times production rate compared to traditional methods for lipid nanoparticles (LNPs). Results demonstrate superior delivery of LNPS generated using PMD in mice, showing potential for emerging clinical applications such as RNA therapeutics and vaccines.

NANO LETTERS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Namit Chaudhary et al.

Summary: mRNA vaccines have been established as a rapid, effective, and safe approach for protecting individuals from infectious diseases, especially during the COVID-19 pandemic. Further research is needed to optimize mRNA vaccine design, delivery, and applications for a range of infectious diseases.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Article Engineering, Chemical

Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis

Rafael G. Ferreira et al.

Summary: The COVID-19 pandemic has led to the rapid development of various vaccines, with some successful ones based on the adenoviral vector platform. This study designed, simulated, and economically evaluated two baseline processes for producing COVID-19 adenoviral vector vaccines, and found that perfusion cell culture was more cost-effective and required less capital investment than batch cell culture. The results suggest that adenoviral vector vaccines can be practically mass-produced at low cost.

PROCESSES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

mRNA vaccines for COVID-19: what, why and how

Jung Woo Park et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has led to significant impact on human lives, with mRNA vaccines emerging as promising candidates due to their rapid development time, cost-effectiveness, versatility in design, and proven ability to induce immune response.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Editorial Material Medicine, Research & Experimental

Prototype pathogen approach for pandemic preparedness: world on fire

Barney S. Graham et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation

Jieliang Wang et al.

AAPS PHARMSCITECH (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Current Status of COVID-19 (Pre)Clinical Vaccine Development

Tingting Ye et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

Kaja Abbas et al.

Lancet Global Health (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

Paul F. McKay et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study

Wei Wang et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

Carla B. Roces et al.

PHARMACEUTICS (2020)

添加到收藏夹

Article Immunology

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components

Sofiya Fedosyuk et al.

VACCINE (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines

Kimberly J. Hassett et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

添加到收藏夹

Correction Biochemical Research Methods

Emerging Technologies for Low-Cost, Rapid Vaccine Manufacture (vol 14, 1800376, 2019)

Zoltan Kis et al.

BIOTECHNOLOGY JOURNAL (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses

Annette B. Vogel et al.

MOLECULAR THERAPY (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

添加到收藏夹

Article Immunology

Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats

Jeff Sedita et al.

VACCINE (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Models for predicting the evolution of influenza to inform vaccine strain selection

Joseph K. Agor et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

添加到收藏夹

Article

Average Batch Failure Rate Worsens

Eric S. Langer

Genetic Engineering & Biotechnology News (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

mRNA vaccine delivery using lipid nanoparticles

Andreas M. Reichmuth et al.

THERAPEUTIC DELIVERY (2016)

添加到收藏夹

Review Immunology

Considerations of strategies to provide influenza vaccine year round

Philipp Lambach et al.

VACCINE (2015)

添加到收藏夹

Review Immunology

Self-replicating alphavirus RNA vaccines

Karl Ljungberg et al.

EXPERT REVIEW OF VACCINES (2015)

添加到收藏夹

Article Multidisciplinary Sciences

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

Matthew D. J. Dicks et al.

PLOS ONE (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

Developing mRNA-vaccine technologies

Thomas Schlake et al.

RNA BIOLOGY (2012)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Sobol' sensitivity analysis of a complex environmental model

Jiri Nossent et al.

ENVIRONMENTAL MODELLING & SOFTWARE (2011)

添加到收藏夹

Review Pharmacology & Pharmacy

Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors

Maria De Jesus et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)

添加到收藏夹

Article Engineering, Industrial

The identification of model effective dimensions using global sensitivity analysis

Sergei Kucherenko et al.

RELIABILITY ENGINEERING & SYSTEM SAFETY (2011)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Variance based sensitivity analysis of model output. Design and estimator for the total sensitivity index

Andrea Saltelli et al.

COMPUTER PHYSICS COMMUNICATIONS (2010)

添加到收藏夹

Article Chemistry, Physical

High dimensional model representations

GY Li et al.

JOURNAL OF PHYSICAL CHEMISTRY A (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.